Patients with higher levels of extravalvular cardiac damage prior to TAVR or SAVR face a higher risk of dying within two years, according to new findings presented at EuroPCR 2022 in Paris.
The device is a novel self-operated prenatal home ultrasound solution that enables pregnant women to self-scan for remote clinical assessment by their healthcare provider when the device is combined with their smartphone.
“We need to commit to changing the supply chain so that a single event in a faraway country does not put us in this predicament again," experts wrote in a new special report shared by Radiology.
Researchers at a quaternary academic medical center have developed a short-term workaround that they report is now reducing the institution’s consumption of Omnipaque (iohexol) by more than 50% without compromising care quality.
Randall Thompson, MD, immediate past president of the American Society of Nuclear Cardiology (ASNC), explains two key advances in cardiac nuclear imaging.